CAPTRUST Financial Advisors
EXAS

CAPTRUST Financial Advisors’s Exact Sciences EXAS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,780
Closed -$3.13M – 3062
2025
Q4 		$3.13M Buy
30,780
+356
+1% +$28.6K 0.01% 872
2025
Q3 		$1.66M Buy
30,424
+7,897
+35% +$395K ﹤0.01% 1122
2025
Q2 		$1.2M Buy
22,527
+15,233
+209% +$774K ﹤0.01% 1248
2025
Q1 		$316K Buy
7,294
+414
+6% +$21K ﹤0.01% 1907
2024
Q4 		$387K Sell
6,880
-2,553
-27% -$159K ﹤0.01% 1756
2024
Q3 		$643K Buy
9,433
+1,854
+24% +$105K ﹤0.01% 1444
2024
Q2 		$320K Sell
7,579
-937
-11% -$51.6K ﹤0.01% 1779
2024
Q1 		$588K Sell
8,516
-8,916
-51% -$564K ﹤0.01% 1403
2023
Q4 		$1.29M Buy
17,432
+2,835
+19% +$186K ﹤0.01% 1120
2023
Q3 		$996K Sell
14,597
-2,393
-14% -$203K ﹤0.01% 1212
2023
Q2 		$1.6M Buy
16,990
+401
+2% +$31.3K 0.01% 927
2023
Q1 		$1.12M Buy
16,589
+1,775
+12% +$114K ﹤0.01% 972
2022
Q4 		$733K Buy
14,814
+1,119
+8% +$45.7K ﹤0.01% 1137
2022
Q3 		$445K Buy
13,695
+2,896
+27% +$119K ﹤0.01% 1304
2022
Q2 		$425K Buy
10,799
+2,878
+36% +$154K ﹤0.01% 1225
2022
Q1 		$554K Buy
7,921
+699
+10% +$51.1K ﹤0.01% 1103
2021
Q4 		$562K Buy
7,222
+516
+8% +$45.5K ﹤0.01% 1061
2021
Q3 		$640K Buy
6,706
+435
+7% +$45.9K 0.01% 930
2021
Q2 		$780K Sell
6,271
-149
-2% -$17.8K 0.01% 821
2021
Q1 		$846K Buy
6,420
+450
+8% +$61.6K 0.01% 758
2020
Q4 		$791K Buy
5,970
+339
+6% +$41K 0.01% 677
2020
Q3 		$592K Sell
5,631
-2,200
-28% -$190K 0.01% 667
2020
Q2 		$685K Sell
7,831
-49
-0.6% -$3.92K 0.01% 604
2020
Q1 		$440K Sell
7,880
-253
-3% -$20.5K 0.01% 619
2019
Q4 		$777K Buy
8,133
+6,325
+350% +$556K 0.01% 568
2019
Q3 		$163K Buy
1,808
+26
+1% +$2.96K 0.01% 622
2019
Q2 		$210K Buy
1,782
+804
+82% +$81K 0.01% 546
2019
Q1 		$85K Buy
978
+878
+878% +$74.7K ﹤0.01% 744
2018
Q4 		$6K Hold
100
– – ﹤0.01% 1303
2018
Q3 		$8K Hold
100
– – ﹤0.01% 1271
2018
Q2 		$6K Hold
100
– – ﹤0.01% 1292
2018
Q1 		$4K Hold
100
– – ﹤0.01% 1179
2017
Q4 		$5K Hold
100
– – ﹤0.01% 1119
2017
Q3 		$5K Buy
+100
New +$4.03K ﹤0.01% 487

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

CAPTRUST Financial Advisors's EXAS Position: Q1 2026 in Review

CAPTRUST Financial Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 30,780 shares — an estimated $3.13M sold.

CAPTRUST Financial Advisors first reported a position in EXAS in Q3 2017 and held it in 34 quarters. The position peaked at $3.13M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • CAPTRUST Financial Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 30,780 Exact Sciences shares in Q1 2026, an estimated $3.13M.
  • CAPTRUST Financial Advisors first reported a position in Exact Sciences in Q3 2017 and held it in 34 quarters.
  • CAPTRUST Financial Advisors's Exact Sciences position peaked at $3.13M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.